glutathione in the cell Dynamics Subcellular Compartments and Implications for Drug Development Glutathione - an overview |

Description

Theate I, van Baren N, Pilotte L, Moulin P, Larrieu P, Renauld JC, et al

Importantly, FRs safety and efficacy have been validated through the recent FDA approval of mirvetuximab soravtansine-gynx for FR-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers 32,33

Its anti-inflammatory effects, largely driven by thymoquinone, exhibit broad mechanistic activity, though current evidence primarily comes from preclinical studies rather than direct comparisons with established pharmacological agents

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

Several studies have also shown that female-gender bladder cancer patients are more likely to experience recurrence or progression compared with male-gender patients with matched stage and grade disease [47, 48]